Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Virtual reality to reduce pain and anxiety during outpatient urology procedures

Official title: VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures: a Post-marketing Clinical Investigation of REALICA

Run by Istituto Oncologico Veneto IRCCS · NCT07338292 · Data updated 2026-11-12

This trial will try a virtual reality headset (REALICA®) to reduce pain and anxiety for adults having outpatient urology procedures such as circumcision, prostate biopsy, or flexible cystoscopy.

More Anxiety trials

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment56 (estimated)
SponsorIstituto Oncologico Veneto IRCCS
Academic / other
Locations1 site (Padova)
StatusRecruiting
StartedDecember 17, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedNovember 10, 2026
Trial IDNCT07338292 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) who are undergoing one of the listed outpatient urological procedures for the first time, can understand instructions, and can give informed consent are eligible.

Probably not a fit

Patients with contraindications to virtual reality (e.g., uncontrolled photosensitive epilepsy, significant neurological/ophthalmologic/ENT disorders), severe psychiatric or major cardiovascular disease, recent relevant urologic manipulations, or absolute contraindications to the planned procedure are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Outpatient urological procedures can cause significant preoperative anxiety and anticipatory pain, which may lead to physiological stress and poorer patient experience. This trial uses REALICA®, a CE-marked virtual reality hypnosis system, delivered during routine ambulatory urological procedures to provide immersive relaxation and guided hypnotic scripts. Participants receiving the device will be compared with routine clinical practice to determine whether VRH lowers procedural pain and anxiety and limits need for pharmacological sedation. The study also monitors patient satisfaction and peri-procedural stress indicators to gauge clinical and operational benefits.

Why it matters

Potential benefit: If successful, the intervention could reduce patient-reported pain and anxiety during procedures, lower sedative use, and improve overall patient experience and throughput in outpatient urology.

How similar studies have gone: Previous studies of virtual reality and virtual reality hypnosis have shown reductions in procedural pain and anxiety in various settings and preliminary evidence in prostate biopsy is promising, but systematic trials in urology remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male/female with age ≥ 18 years
* Patient who are undergoing one of the interventions mentioned in the study for the first time;
* Eligibility for minimally invasive ambulatory urological procedures, possibly requiring vascular access (circumcision, prostate biopsy, flexible cystoscopy);
* Ability to understand instructions and complete study questionnaires;
* Signed informed consent.

Exclusion Criteria:

* Absolute contraindications to the planned urological procedure (e.g., active urinary tract infection, anatomical urethral abnormalities);
* Recent urological manipulations (e.g., urethral dilation, bladder biopsy, insertion or removal of a double-J stent);
* Medical contraindications to the use of virtual reality, including uncontrolled photosensitive epilepsy and relevant neurological, ophthalmologic, or otolaryngologic disorders;
* Presence of severe psychiatric disorders or major cardiovascular diseases that may interfere with study participation;
* Previous adverse reactions to virtual reality exposure;
* Use of analgesic medications within 24 hours prior to the procedure;
* Use of drugs that may alter consciousness or impair the ability to complete psychological assessments;
* Severe communication disabilities or significant hearing impairment that would prevent completion of questionnaires.

Where it's running

  • Istituto Oncologico Veneto IRCCS
    Padova, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.